Company / Interest Expense per Share
Collegium Pharmaceutical, Inc. Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$2.62
FY2023
5-year range
$0.62 / $2.62
FY2019-FY2023
Trend
+40.0%
vs FY2022
Sector context
#5 of 45
Health Care
What the data says
Collegium Pharmaceutical, Inc.'s interest expense per share of $2.62 is higher than 89% of companies in the Health Care sector (FY2023). Interest Expense per Share has fluctuated over the past 7 years, ranging from $0.00 in FY2016 to $2.62 in FY2023.
Based on SEC 10-K filings.
2.62 in FY2023 with a 5-year CAGR of +33.6%. Top quartile in the Health Care sector.
Increased from $0.62 to $2.62 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +46.3%
- 5-Year CAGR
- +33.6%
- 10-Year CAGR
- -
Sector benchmark
-85.3% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 40.0% year-over-year.
- Ranks #5 out of 45 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $2.62 | +40.0% |
| FY2022 | $1.87 | +199.1% |
| FY2021 | $0.62 | -25.2% |
| FY2020 | $0.83 | +2953.7% |
| FY2019 | $0.03 | -95.6% |
| FY2018 | $0.61 | - |
| FY2017 | - | - |
| FY2016 | $0.00 | -86.0% |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026